Align Technology, Inc. (NASDAQ:ALGN - Free Report) - Analysts at Leerink Partnrs reduced their Q1 2025 earnings per share (EPS) estimates for shares of Align Technology in a report released on Wednesday, April 9th. Leerink Partnrs analyst M. Cherny now anticipates that the medical equipment provider will post earnings per share of $1.51 for the quarter, down from their previous forecast of $1.56. Leerink Partnrs currently has a "Strong-Buy" rating on the stock. The consensus estimate for Align Technology's current full-year earnings is $7.98 per share. Leerink Partnrs also issued estimates for Align Technology's FY2028 earnings at $11.35 EPS.
Other research analysts also recently issued research reports about the stock. Needham & Company LLC reaffirmed a "hold" rating on shares of Align Technology in a report on Thursday, February 6th. Jefferies Financial Group dropped their price target on Align Technology from $285.00 to $260.00 and set a "buy" rating for the company in a research report on Thursday, January 23rd. Wells Fargo & Company began coverage on shares of Align Technology in a research note on Friday, February 14th. They issued an "overweight" rating and a $255.00 target price on the stock. Morgan Stanley decreased their target price on Align Technology from $280.00 to $272.00 and set an "overweight" rating for the company in a research report on Thursday, February 6th. Finally, Leerink Partners raised Align Technology from a "market perform" rating to an "outperform" rating and increased their price target for the stock from $235.00 to $280.00 in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $256.90.
Check Out Our Latest Stock Analysis on Align Technology
Align Technology Stock Performance
Shares of NASDAQ:ALGN traded up $4.11 during trading on Friday, reaching $168.26. 463,200 shares of the stock traded hands, compared to its average volume of 868,166. The stock has a 50-day moving average of $175.16 and a two-hundred day moving average of $206.13. Align Technology has a 52-week low of $141.74 and a 52-week high of $327.49. The stock has a market cap of $12.32 billion, a P/E ratio of 29.99, a price-to-earnings-growth ratio of 2.24 and a beta of 1.73.
Align Technology (NASDAQ:ALGN - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share for the quarter, missing the consensus estimate of $2.43 by ($0.47). Align Technology had a return on equity of 13.84% and a net margin of 10.54%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Neo Ivy Capital Management acquired a new position in Align Technology in the third quarter valued at $32,000. Picton Mahoney Asset Management increased its holdings in Align Technology by 69.9% in the fourth quarter. Picton Mahoney Asset Management now owns 141 shares of the medical equipment provider's stock valued at $30,000 after buying an additional 58 shares during the last quarter. GKV Capital Management Co. Inc. bought a new stake in shares of Align Technology in the 4th quarter valued at approximately $31,000. Aster Capital Management DIFC Ltd acquired a new position in shares of Align Technology in the 4th quarter valued at about $35,000. Finally, Private Trust Co. NA lifted its holdings in shares of Align Technology by 113.4% in the 4th quarter. Private Trust Co. NA now owns 175 shares of the medical equipment provider's stock worth $36,000 after purchasing an additional 93 shares during the last quarter. 88.43% of the stock is currently owned by hedge funds and other institutional investors.
Align Technology Company Profile
(
Get Free Report)
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
See Also
Before you consider Align Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.
While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
